Picture of Abingdon Health logo

ABDX — Abingdon Health Share Price

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m-21.14%
3m
6m
1yr
Volume Change (%)
10d/3m
Price vs... (%)
52w High-73.66%
50d MA
200d MA

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Jun 202230th Jun 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Abingdon Health EPS forecast chart

Profile Summary

Abingdon Health Ltd is a technology enabled lateral flow diagnostics company focused on developing, manufacturing and commercializing immunoassay tests and reader systems and provides lateral flow assay and reader contract services, and routine manufacturing services. It offers lateral flow reader assay original equipment manufacturer (OEM) solutions. Its lateral flow assay and reader services include later flow assay development, lateral flow manufacturing, quantitative lateral flow test reader customization, pharmaceutical diagnostic solutions and quotation request. Its products are AbC-19 Rapid Test, Nucleic Acid Lateral Flow Immunoassays and Seralite Free Light Chain (FLC) Serum. Abc-19 is a rapid test for the detection of IgG neutralizing antibodies to SARS-CoV-2 (COVID-19). Its Seralite Free Light Chain (FLC) product range is used as an aid in the diagnosis and management of multiple myeloma. The Seralite-FLC product range includes Seralite- FLC Serum and Seralite-FLC Urine.

Directors

Last Annual
June 30th, 2021
Last Interim
June 30th, 2021
Incorporated
January 16th, 2008
Public Since
January 1st, 1970
No. of Employees
119
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
gb flag iconLondon Stock Exchange
Shares in Issue
95,699,114

ABDX Share Price Performance

Latest News for ABDX

Upcoming Events for ABDX

Full Year 2020 Abingdon Health PLC Earnings Release

Similar to ABDX

Picture of Advanced Medical Solutions logo

Advanced Medical Solutions

gb flag iconLondon Stock Exchange

Picture of Advanced Oncotherapy logo

Advanced Oncotherapy

gb flag iconLondon Stock Exchange

Picture of Angle logo

Angle

gb flag iconLondon Stock Exchange

Picture of Belluscura logo

Belluscura

gb flag iconLondon Stock Exchange

Picture of ConvaTec logo

ConvaTec

gb flag iconLondon Stock Exchange

FAQ

Or unlock with your email

Or unlock with your email